Bipolar disorder affects 40-50 million people globally, with genetic heritability between 60-80%, and can be triggered by both positive and negative life events, including promotions or new ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression ...

Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

Towards the end of life, you might want to make decisions about your care. This includes any instructions for refusing treatment. It can sometimes be very difficult to know what care and treatment to ...